UTERINE CARCINOSARCOMA

Clinical trials for UTERINE CARCINOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new UTERINE CARCINOSARCOMA trials appear

Sign up with your email to follow new studies for UTERINE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug duo tested for Tough-to-Treat gynecologic cancer

Disease control Ongoing

This study is testing whether a combination of two drugs, pembrolizumab and lenvatinib, can help control advanced uterine or ovarian carcinosarcoma, a rare and aggressive cancer. It is for up to 40 patients whose cancer has continued to grow after at least one prior chemotherapy …

Matched conditions: UTERINE CARCINOSARCOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

UTERINE CARCINOSARCOMA

Get alerted when new UTERINE CARCINOSARCOMA trials appear

New drug duo tested for Tough-to-Treat gynecologic cancer